^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
INFORM HER-2/neu

Company:
Roche
Type:
FDA Approved
Related tests:

Details

Evidence
News
INFORM HER-2/neu is a in situ hybridization (FISH) DNA probe assay that determines the qualitative presence of HER-2/neu gene amplification on formalin-fixed, paraffin-embedded human breast tissue as an aid to stratify breast cancer patients according to risk for recurrence or disease-related death. It is indicated for use as an adjunct to existing clinical and pathologic information currently used as prognostic indicators in the risk stratification of breast cancer in patients who have had a priary, invasive, localized breast carcinoma and who are lymph node-negative.
Cancer:
Breast Cancer
Gene:
HER-2 (Human epidermal growth factor receptor 2)
Drug:
Herceptin (trastuzumab)
Method:
Fluorescence in situ hybridization (FISH)
Approvals
Date
Cancer
Gene
Drug
By